In-Depth Characterization for Methionine Oxidization in Complementary Domain Region by Hydrophobic Interaction ChromatographyClick to copy article linkArticle link copied!
- Liu TangLiu TangAnalytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Liu Tang
- Huiliang GengHuiliang GengAnalytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Huiliang Geng
- Lei Zhang*Lei Zhang*E-mail: [email protected]Analytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Lei Zhang
- Xinyi WangXinyi WangAnalytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Xinyi Wang
- Mengdan FeiMengdan FeiAnalytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Mengdan Fei
- Boyuan YangBoyuan YangAnalytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Boyuan Yang
- Haijie SunHaijie SunAnalytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Haijie Sun
- Zhongli Zhang*Zhongli Zhang*E-mail: [email protected]Analytical Science Development, Henlius Biologics Co., Ltd, Shanghai 201616, ChinaMore by Zhongli Zhang
Abstract
The oxidation of the complementarity-determining region (CDR) in monoclonal antibodies (mAbs) is a critical quality attribute that can affect the clinical efficacy and safety of recombinant mAb therapeutics. In this study, a robust hydrophobic interaction chromatography (HIC) method was developed to quantify and characterize CDR oxidation variants in mAb-A by using a Proteomix Butyl-NP5 column. The HIC analysis revealed oxidation variants that eluted earlier than the main species with weaker hydrophobicity. It was found that Met105 in the CDR was more susceptible to oxidation. Additionally, it was noted that the oxidation of Met105 on a single heavy chain resulted in elution at a distinct position compared to the oxidation on two heavy chains. This observation led to the fractionation and enrichment of the oxidized variants for further evaluation of their biofunction. The study also demonstrated that the oxidation of Met105 did not impact the antigen-binding capacity but significantly reduced the PD-1/PD-L1 blockade activity of mAb-A. The HIC method, which was employed to quantify CDR oxidation, underwent validation and was subsequently utilized for stability studies as well as for assessing the similarity between mAb-A and its reference product.
Cited By
This article has not yet been cited by other publications.
Article Views
Altmetric
Citations
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.